Health Strategies Group experts have been researching and providing insight to pharmaceutical and biotechnology professionals since 1992.

See below for a listing of white papers published by our firm.

	This is Going to Hurt: Forecasting Amid Public Sector Growth and Change, October 2009. By Heather Lee Ingram Whipple and Dee Miller Prince. Assesses anticipated market shifts over the next five years, the strategic implications these shifts will have on the pharmaceutical and biotech segments, and what should be considered when making future income and revenue projects.
	Predicting Future Physician Prescribing Decisions (Updated May 2010), July 2009. By Rick Rosenthal and Manny Gaspar. Traditional sales force effectiveness metrics are no longer effective. Our experts define an evolving approach called the PITCh index, which identifies four universal forces that contribute to physicians' prescribing decisions.
	Oncology Sales Success - It's All About the Patient, July 2009. By Denise Woltemath. Every medical specialty is different, requiring a varying sales approach based on each specialty's needs and values. In this report, Health Strategies Group outlines the behaviors, knowledge, and support that Oncologists value in pharmaceutical representatives.
	The Evolving Medicaid Landscape: Customer segments and coordination are key., November 2008. By Joe deSimone and Dee Prince. This clear and informative report, written by our Medicaid experts, is an easy first step toward understanding how the Medicaid market is changing, the opportunities it creates, and how we can help you make the best business decision to succeed.